Logo
x

Search

Subscribe Now

gastric

Ethicon Launches Echelon Circular as the First Powered Circular Stapler for Colorectal Gastric and Thoracic Surgery

Ethicon Launches Echelon Circular as the First Powered Circular Stapler for Colorectal Gastric and Thoracic Surgery

  • September 25, 2019
Oncologie and Merck Collaborate to Evaluate Bavituximab + Keytruda for Treatment of Advanced Gastric or Gastroesophageal Cancer

Oncologie and Merck Collaborate to Evaluate Bavituximab + Keytruda for Treatment of Advanced Gastric or Gastroesophageal Cancer

  • August 12, 2019
Samsung Bioepis' Biosimilar Transtuzumab Ontruzant (transtuzumab-dttb)- Receives US FDA Approval for Oncology Indications

Samsung Bioepis' Biosimilar Transtuzumab Ontruzant (transtuzumab-dttb)- Receives US FDA Approval for Oncology Indications

  • January 21, 2019
Astellas at ASCO 2024: Ahsan Arozullah in an Illuminating Dialogue Exchange with PharmaShots

    Astellas at ASCO 2024: Ahsan Arozullah in an Illuminating Dialogue Exchange with PharmaShots

    • September 16, 2024
    Phanes Therapeutics Reports the First Patient Dosing with PT886 in P-I/II Study for Pancreatic and Gastric Cancer

      Phanes Therapeutics Reports the First Patient Dosing with PT886 in P-I/II Study for Pancreatic and Gastric Cancer

      • September 10, 2024
      The NMPA Clears Shanghai Henlius’ IND Application of HLX17 (Biosimilar, Keytuda) for Treating Solid Tumors

        The NMPA Clears Shanghai Henlius’ IND Application of HLX17 (Biosimilar, Keytuda) for Treating Solid Tumors

        • September 2, 2024
        Insights+: EMA Marketing Authorization of New Drugs in July 2024

          Insights+: EMA Marketing Authorization of New Drugs in July 2024

          • August 14, 2024
          AstraZeneca and Daiichi Sankyo’s Enhertu Receives the NMPA’s Conditional Approval to Treat Gastric Cancer

            AstraZeneca and Daiichi Sankyo’s Enhertu Receives the NMPA’s Conditional Approval to Treat Gastric Cancer

            • August 13, 2024
            ALX Oncology Provides Update on P-II (ASPEN-06) Study of Evorpacept to Treat Gastric Cancer

              ALX Oncology Provides Update on P-II (ASPEN-06) Study of Evorpacept to Treat Gastric Cancer

              • August 1, 2024
              Image

              Incisive News in 3 Shots.

              Contact Us

              Our Information

              Follow Us

              Copyright © 2025 PharmaShots - All Rights Reserved.